Cas no 24786-52-5 (5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one)
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one Chemical and Physical Properties
Names and Identifiers
-
- 5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one
- 5-amino-6-bromo-1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one(SALTDATA: FREE)
- 5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one
- 5-Amino-6-brom-1,3-dimethyl-benzimidazol-2-on
- 5-amino-6-bromo-1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one
- AC1NHU6D
- CTK4F4389
- HMS1604P19
- SBB028122
- STK744101
- ZAA78652
- BRD-K15649766-001-01-4
- DTXSID30406399
- AKOS000113818
- 5-amino-6-bromo-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one, AldrichCPR
- SCHEMBL17534190
- CS-0067123
- 5-amino-6-bromo-1,3-dimethyl-1,3-benzodiazol-2-one
- SXPRALARBJCCIH-UHFFFAOYSA-N
- 2H-Benzimidazol-2-one, 5-amino-6-bromo-1,3-dihydro-1,3-dimethyl-
- 24786-52-5
- MFCD06618584
- 5-AMINO-6-BROMO-1,3-DIMETHYL-1,3-DIHYDRO-2H-1,3-BENZIMIDAZOL-2-ONE
- D73358
- 5-amino-6-bromo-1,3-dimethylbenzimidazol-2-one
- CS-15919
-
- MDL: MFCD06618584
- Inchi: 1S/C9H10BrN3O/c1-12-7-3-5(10)6(11)4-8(7)13(2)9(12)14/h3-4H,11H2,1-2H3
- InChI Key: SXPRALARBJCCIH-UHFFFAOYSA-N
- SMILES: BrC1C(=CC2=C(C=1)N(C)C(N2C)=O)N
Computed Properties
- Exact Mass: 255.0008
- Monoisotopic Mass: 255.00072g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 14
- Rotatable Bond Count: 0
- Complexity: 260
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 49.6?2
Experimental Properties
- Density: 1.645±0.06 g/cm3 (20 oC 760 Torr),
- Solubility: Very slightly soluble (0.82 g/l) (25 o C),
- PSA: 49.57
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM274414-1g |
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one |
24786-52-5 | 95% | 1g |
$608 | 2021-06-16 | |
| Fluorochem | 060237-250mg |
5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one |
24786-52-5 | 95% | 250mg |
£124.00 | 2022-03-01 | |
| Fluorochem | 060237-1g |
5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one |
24786-52-5 | 95% | 1g |
£232.00 | 2022-03-01 | |
| Fluorochem | 060237-5g |
5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one |
24786-52-5 | 95% | 5g |
£744.00 | 2022-03-01 | |
| abcr | AB267805-250 mg |
5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one, 95%; . |
24786-52-5 | 95% | 250 mg |
€231.70 | 2023-07-20 | |
| abcr | AB267805-1 g |
5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one, 95%; . |
24786-52-5 | 95% | 1 g |
€385.20 | 2023-07-20 | |
| abcr | AB267805-5 g |
5-Amino-6-bromo-1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one, 95%; . |
24786-52-5 | 95% | 5g |
€1,001.00 | 2022-06-11 | |
| Chemenu | CM274414-250mg |
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one |
24786-52-5 | 95% | 250mg |
$100 | 2024-07-28 | |
| Chemenu | CM274414-1g |
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one |
24786-52-5 | 95% | 1g |
$201 | 2024-07-28 | |
| Chemenu | CM274414-5g |
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one |
24786-52-5 | 95% | 5g |
$632 | 2024-07-28 |
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one Suppliers
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one Related Literature
-
M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
Additional information on 5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one
Comprehensive Overview of 5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one (CAS No. 24786-52-5)
5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one (CAS No. 24786-52-5) is a specialized heterocyclic compound gaining attention in pharmaceutical and agrochemical research. This benzimidazole derivative features a unique molecular structure with amino and bromo functional groups, making it a versatile intermediate for synthesizing bioactive molecules. Recent studies highlight its potential in drug discovery, particularly for targeting enzyme inhibition pathways, aligning with the growing demand for small-molecule therapeutics in oncology and infectious diseases.
The compound’s 1,3-dimethyl substitution pattern enhances its stability, a critical factor for high-throughput screening applications. Researchers are exploring its role in developing kinase inhibitors, a hot topic in precision medicine. With the rise of AI-driven drug design, 24786-52-5 has been flagged in computational databases as a scaffold for fragment-based drug discovery (FBDD), addressing queries like "novel benzimidazole scaffolds for cancer therapy." Its electron-rich aromatic system also makes it relevant for organic electronics, tapping into the surge in green chemistry innovations.
From a synthetic perspective, 5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one is synthesized via Pd-catalyzed cross-coupling reactions, a method frequently searched in organic synthesis forums. Its bromo group allows further functionalization, answering common questions like "how to modify brominated benzimidazoles." Analytical data (HPLC, NMR) confirm >98% purity, meeting GMP standards for preclinical studies. The compound’s solubility in DMSO and DMF aligns with lab protocols, a practical detail often overlooked in technical sheets.
Market trends show increased interest in custom synthesis of CAS 24786-52-5, driven by contract research organizations (CROs). Its patent landscape reveals applications in antiviral agents, resonating with post-pandemic research priorities. Environmental considerations are addressed via biodegradation studies, a niche yet growing SEO keyword. Storage recommendations (-20°C under argon) cater to long-term stability concerns, a frequent query among purchasers.
In conclusion, 5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one bridges multiple disciplines—from medicinal chemistry to material science. Its dual utility as a pharmacophore and building block ensures sustained relevance, while optimized synthetic routes address cost-efficiency demands. Future research may explore its structure-activity relationships (SAR) to unlock untapped therapeutic potentials.
24786-52-5 (5-Amino-6-bromo-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one) Related Products
- 93740-30-8(Urea, N-(4-bromophenyl)-N,N'-dimethyl-)
- 305790-48-1(6-Bromo-1-methyl-1H-benzodimidazol-2(3H)-one)
- 913297-44-6(7-Bromo-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one)
- 39513-26-3(5-bromo-2,3-dihydro-1H-1,3-benzodiazol-2-one)
- 79759-43-6(2H-Benzimidazol-2-one,5-bromo-1,3-dihydro-1-methyl-3-phenyl-)
- 77585-87-6(3-(4-bromophenyl)-1-methyl-1-phenylurea)
- 20940-43-6(Urea, N'-(3-bromophenyl)-N,N-dimethyl-)
- 79759-42-5(6-bromo-1-phenyl-1,3-dihydro-2H-benzimidazol-2-one)
- 40644-16-4(4-bromo-1,3-dihydrobenzimidazol-2-one)
- 84712-08-3(5-Bromo-1-methyl-3H-1,3-benzodiazol-2-one)